NHS medics in Edinburgh have carried out the United Kingdom’s first testicular tissue transplant on a 19‑year‑old patient, aiming to restore his ability to produce sperm after chemotherapy left him infertile. The procedure, performed in August 2026, involves re‑implanting tissue that was removed and frozen three years earlier, before the teenager began treatment for a serious blood disorder.
The Procedure and Its Purpose
The transplant took place at NHS Lothian, where surgeons grafted the previously cryopreserved testicular tissue back into the patient’s body. The goal is for the grafted tissue to resume spermatogenesis, the process by which sperm are generated from puberty onward. The tissue contains spermatogonial stem cells, the specialised cells responsible for sperm production. Doctors will monitor semen analyses over the coming months to determine whether viable sperm appear.
This intervention addresses a gap in current fertility preservation options. While adolescent and adult males can bank semen before chemotherapy, pre‑pubescent boys lack that possibility because they do not yet produce sperm. By freezing testicular tissue before gonadotoxic therapy, clinicians hope to safeguard future fertility for children facing cancer or other treatments that damage the testes.
Patient’s Journey and Hope
The teenager, who has asked to remain anonymous, described the experience as profoundly personal. “Fertility is something I’ve struggled with personally for a long time,” he said. He had always imagined fatherhood but, after chemotherapy, began to accept that biological children might never be possible for him.
He added: “We don’t know yet whether it will work, but knowing that there is now even a possibility means more to me than I can really put into words.” Expressing gratitude, he noted: “I’m incredibly grateful to everyone for giving me this opportunity and for all the work that has made it possible. I also hope that being part of this research means that, in the future, other young people in the same position can have that hope too.”
Research Background and Support
The operation is the culmination of a decade‑long research programme led by the University of Edinburgh. Rod Mitchell, professor of developmental endocrinology at Edinburgh’s Institute for Regeneration and Repair and a consultant paediatric endocrinologist at NHS Lothian, explained the significance: “This is a big step towards helping boys facing treatments that damage their fertility to have children of their own.” He recalled that ten years ago the team began freezing and storing testicular tissue from boys before they started chemotherapy, precisely to preserve their reproductive potential.
Tracey Gillies, medical director at NHS Lothian, labelled the transplant a “landmark procedure”. She said: “We are grateful to the patient and his family for helping advance research that could transform care for others in the future.” The project received financial backing from Children with Cancer UK, a charity dedicated to improving outcomes for young patients.
What Comes Next
Although the transplant is novel in the UK, it follows a similar case reported in May 2026 by the Guardian. In that instance, a man whose testicular tissue had been frozen before childhood chemotherapy and re‑implanted 16 years later succeeded in producing sperm. Worldwide, more than 3,100 individuals have had testicular tissue stored for potential future use, with over 1,200 of those patients in the United Kingdom, according to the University of Edinburgh.
Clinicians will now wait for the results of semen tests, expected within a few months. If sperm are detected, the patient could potentially use assisted reproductive techniques to achieve biological parenthood. A negative outcome would still provide valuable data for refining the technique and improving success rates for future recipients.
Why it Matters
This milestone offers tangible hope to countless boys who undergo gonadotoxic therapies and face the prospect of infertility later in life. By demonstrating that frozen testicular tissue can be successfully re‑implanted and may restart sperm production, the procedure opens a viable fertility preservation pathway for a group previously left without options. Should the technique prove reliable, it could shift clinical practice worldwide, allowing more young cancer survivors to realise their aspirations of parenthood and reducing the long‑term psychosocial impact of treatment‑related infertility.